Steven G. Blanchard

10.6k citations

62 papers · 8.1k indexed · 3 hit papers · h-index 35

Molecular Biology top 1%
Oncology top 1%
Surgery top 2%
Physiology top 2%
Genetics top 2%

Co-authors: Timothy M. Willson Derek J. Parks Steven A. Kliewer Thomas G. Consler Jürgen M. Lehmann Julie B. Stimmel Randy K. Bledsoe Gyan Chandra
Topics: Peroxisome Proliferator-Activated Receptors (18 papers)Receptor Mechanisms and Signaling (8 papers)Inflammatory mediators and NSAID effects (8 papers)
Cited by: Pharmacology Biochemistry Oncology
Journals: Nature Science Proceedings of the National Academy of Sciences
Partner nations: United States France United Kingdom

In The Last Decade

Steven G. Blanchard

61 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bile Acids: Natural Ligands for an Orphan Nuclear Receptor

1999 1.9k citations Derek J. Parks, Steven G. Blanchard et al. profile →
Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptors

1999 938 citations H. Eric Xu, Millard H. Lambert et al. Molecular Cell profile →
Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands

2000 684 citations Linda B. Moore, Derek J. Parks et al. Journal of Biological Chemistry profile →

Peers

Countries citing papers authored by Steven G. Blanchard

Since Specialization

Citations

This map shows the geographic impact of Steven G. Blanchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven G. Blanchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven G. Blanchard more than expected).

Fields of papers citing papers by Steven G. Blanchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven G. Blanchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven G. Blanchard. The network helps show where Steven G. Blanchard may publish in the future.

Co-authorship network of co-authors of Steven G. Blanchard

This figure shows the co-authorship network connecting the top 25 collaborators of Steven G. Blanchard. A scholar is included among the top collaborators of Steven G. Blanchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven G. Blanchard. Steven G. Blanchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CC2D2A mutations lead to variable phenotypes in a family with retinal dystrophy 2017 ·Investigative Ophthalmology & Visual Science ·Cécile Méjécase,Saddek Mohand‐Saïd,(unknown),Aurélie Hummel,Saïd El Shamieh,Aline Antonio,Fiona Boyard,Christel Condroyer,Christelle Michiels,Steven G. Blanchard,Mélanie Letexier,Jean‐Paul Saraiva,José‐Alain Sahel,Christina Zeitz,Isabelle Audo	2
2	Pathview Web: user friendly pathway visualization and data integration 2017 ·Nucleic Acids Research ·Weijun Luo,Gaurav Pant,(unknown),Steven G. Blanchard,Cory Brouwer	295
3	Whole exome sequencing for determination of tumor mutation load in liquid biopsy from advanced cancer patients 2017 ·PLoS ONE ·Florence Koeppel,Steven G. Blanchard,Cécile Jovelet,Bérengère Génin,Charles Marcaillou,Emmanuel Martin,Etienne Rouleau,Éric Solary,Jean‐Charles Soria,Fabrice André,Ludovic Lacroix	81
4	Identification of a Novel Homozygous Nonsense Mutation Confirms the Implication of GNAT1 in Rod-Cone Dystrophy 2016 ·PLoS ONE ·Cécile Méjécase,(unknown),Claudine Mayer,Olivier Poch,Saddek Mohand‐Saïd,(unknown),Aline Antonio,Fiona Boyard,Christel Condroyer,Christelle Michiels,Steven G. Blanchard,Mélanie Letexier,Jean‐Paul Saraiva,José‐Alain Sahel,Isabelle Audo,Christina Zeitz	17
5	Genoviz Software Development Kit: Java tool kit for building genomics visualization applications 2009 ·BMC Bioinformatics ·Gregg Helt,(unknown),Ed Erwin,Eric Blossom,Steven G. Blanchard,Stephen A. Chervitz,Cyrus L. Harmon,Ann E. Loraine	20
6	Discovery of Bioavailable Inhibitors of Secretory Phospholipase A2 2006 ·Kluwer Academic Publishers eBooks ·Steven G. Blanchard,Robert Andrews,Peter J. Brown,Liang‐Shang Gan,Frank W. Lee,Achintya K. Sinhababu,(unknown)	4
7	Environmental mercury release, special education rates, and autism disorder: an ecological study of Texas 2005 ·Health & Place ·Raymond F. Palmer,Steven G. Blanchard,(unknown),David S. Mandell,Claudia S. Miller	165
8	Role of PPARα in mediating the effects of phthalates and metabolites in the liver 2004 ·Toxicology ·Paula J. Lapinskas,Sherri Brown,Lisa M. Leesnitzer,Steven G. Blanchard,(unknown),Russell C. Cattley,J. Christopher Corton	141
9	HIV protease inhibitors block adipogenesis and increase lipolysis in vitro 2000 ·Antiviral Research ·James M. Lenhard,Eric S. Furfine,Renu Jain,Olivia Ittoop,Lisa A. Orband‐Miller,Steven G. Blanchard,Mark Paulik,James E. Weiel	135
10	Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligandsbreakdown → 2000 ·Journal of Biological Chemistry ·Linda B. Moore,Derek J. Parks,Stacey A. Jones,Randy K. Bledsoe,Thomas G. Consler,Julie B. Stimmel,Bryan Goodwin,Christopher Liddle,Steven G. Blanchard,Timothy M. Willson,Jon L. Collins,Steven A. Kliewer	684
11	Molecular Recognition of Fatty Acids by Peroxisome Proliferator–Activated Receptorsbreakdown → 1999 ·Molecular Cell ·H. Eric Xu,Millard H. Lambert,Valerie G. Montana,Derek J. Parks,Steven G. Blanchard,Peter J. Brown,Daniel D. Sternbach,Jürgen M. Lehmann,G. Bruce Wisely,Timothy M. Willson,Steven A. Kliewer,Michael V. Milburn	938
12	Synthesis and biological activity of a novel series of indole-derived PPARγ agonists 1999 ·Bioorganic & Medicinal Chemistry Letters ·Brad R. Henke,(unknown),Steven G. Blanchard,Lisa M. Leesnitzer,Robert A. Mook,Kelli D. Plunket,John A. Ray,(unknown),Rayomand J. Unwalla,Timothy M. Willson	29
13	Iterative size-exclusion chromatography coupled with liquid chromatographic mass spectrometry to enrich and identify tight-binding ligands from complex mixtures 1999 ·Tetrahedron ·Roderick G. Davis,Robert J. Anderegg,Steven G. Blanchard	9
14	Development of a Scintillation Proximity Assay for Peroxisome Proliferator-Activated Receptor γ Ligand Binding Domain 1998 ·Analytical Biochemistry ·James S. Nichols,(unknown),Thomas G. Consler,Steven G. Blanchard	95
15	A Fluorescence-Based Assay for Human Type II Phospholipase A2 1994 ·Analytical Biochemistry ·Steven G. Blanchard,(unknown),Derek J. Parks	20
16	Substrate Specificity in Short-Chain Phospholipid Analogs at the Active Site of Human Synovial Phospholipase A2 1994 ·Journal of Medicinal Chemistry ·(unknown),Steven G. Blanchard,(unknown),(unknown),(unknown),(unknown),Mukund M. Mehrotra,Derek J. Parks,(unknown)	16
17	Dietary fat and menstrual-cycle effects on the erythrocyte ghost insulin receptor in premenopausal women 1989 ·American Journal of Clinical Nutrition ·S. J. Bhathena,E. Berlin,J T Judd,(unknown),B. W. Kennedy,Patricia M. Smith,D. Yvonne Jones,Philip R. Taylor,W S Campbell,Steven G. Blanchard	8
18	Characterization of the association of tritiated enkephalin with neuroblastoma cells under conditions optimal for receptor down regulation. 1983 ·Journal of Biological Chemistry ·Steven G. Blanchard,Kwen‐Jen Chang,Pedro Cuatrecasas	40
19	Effects of local anesthetics and histrionicotoxin on the binding of carbamylcholine to membrane-bound acetylcholine receptor 1981 ·Biochemistry ·Susan M. J. Dunn,Steven G. Blanchard,Michael A. Raftery	7
20	Purification of Torpedo californica post-synaptic membranes and fractionation of their constituent proteins 1980 ·Biochemical Journal ·Janet Elliott,Steven G. Blanchard,Wilson C.‐S. Wu,Jeffrey V. Miller,Catherine D. Strader,Paul Hartig,H P Moore,(unknown),Michael A. Raftery	167

About Steven G. Blanchard

Steven G. Blanchard is a scholar working on Biochemistry, Molecular Biology and Cellular and Molecular Neuroscience, having authored 62 papers that have together received 8.1k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (18 papers), Receptor Mechanisms and Signaling (8 papers) and Inflammatory mediators and NSAID effects (8 papers). The work is most often cited by research in Pharmacology (857 citations), Biochemistry (680 citations) and Oncology (2.0k citations). Steven G. Blanchard has collaborated with scholars based in United States, France and United Kingdom. Frequent co-authors include Timothy M. Willson, Derek J. Parks, Steven A. Kliewer, Thomas G. Consler, Jürgen M. Lehmann, Julie B. Stimmel, Randy K. Bledsoe, Gyan Chandra, David D. Moore and Ann Marie Zavacki. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact